Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 84% ± 9% | |
lung | 18 studies | 75% ± 15% | |
intestine | 13 studies | 67% ± 23% | |
brain | 11 studies | 39% ± 18% | |
kidney | 9 studies | 70% ± 20% | |
eye | 9 studies | 50% ± 22% | |
bone marrow | 6 studies | 70% ± 20% | |
lymph node | 6 studies | 88% ± 5% | |
liver | 6 studies | 68% ± 15% | |
pancreas | 5 studies | 79% ± 13% | |
uterus | 5 studies | 84% ± 13% | |
placenta | 4 studies | 82% ± 19% | |
prostate | 4 studies | 81% ± 24% | |
breast | 4 studies | 88% ± 6% | |
heart | 3 studies | 38% ± 16% | |
adipose | 3 studies | 44% ± 28% | |
adrenal gland | 3 studies | 76% ± 12% | |
esophagus | 3 studies | 77% ± 18% | |
skin | 3 studies | 71% ± 23% | |
thymus | 3 studies | 82% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 21125.99 | 1445 / 1445 | 100% | 155.26 | 183 / 183 |
ovary | 100% | 35461.54 | 180 / 180 | 100% | 230.10 | 430 / 430 |
prostate | 100% | 17192.49 | 245 / 245 | 100% | 265.40 | 502 / 502 |
stomach | 100% | 15764.28 | 359 / 359 | 100% | 221.25 | 286 / 286 |
thymus | 100% | 16192.31 | 653 / 653 | 100% | 268.63 | 604 / 605 |
lung | 100% | 15986.75 | 577 / 578 | 100% | 207.07 | 1155 / 1155 |
intestine | 100% | 19521.15 | 966 / 966 | 100% | 268.51 | 526 / 527 |
skin | 100% | 27318.78 | 1809 / 1809 | 100% | 247.05 | 471 / 472 |
uterus | 100% | 22561.25 | 170 / 170 | 100% | 268.61 | 458 / 459 |
bladder | 100% | 22758.19 | 21 / 21 | 100% | 244.16 | 502 / 504 |
breast | 100% | 24596.42 | 459 / 459 | 100% | 319.31 | 1113 / 1118 |
pancreas | 99% | 12656.64 | 326 / 328 | 100% | 208.98 | 178 / 178 |
kidney | 100% | 14552.58 | 89 / 89 | 99% | 189.94 | 890 / 901 |
brain | 98% | 8053.42 | 2600 / 2642 | 100% | 184.33 | 705 / 705 |
adrenal gland | 100% | 15706.87 | 258 / 258 | 98% | 173.07 | 226 / 230 |
liver | 98% | 7390.94 | 221 / 226 | 100% | 145.43 | 404 / 406 |
adipose | 100% | 23095.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 21627.12 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 380.02 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 389.20 | 29 / 29 |
muscle | 100% | 18967.39 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 14527.99 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 290.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 79.51 | 1 / 1 |
peripheral blood | 98% | 14189.09 | 915 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 11456.20 | 833 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015031 | Biological process | protein transport |
GO_0001701 | Biological process | in utero embryonic development |
GO_1905551 | Biological process | negative regulation of protein localization to endoplasmic reticulum |
GO_0005854 | Cellular component | nascent polypeptide-associated complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | BTF3 |
Protein name | Transcription factor BTF3 Transcription factor BTF3 (Nascent polypeptide-associated complex subunit beta) (NAC-beta) (RNA polymerase B transcription factor 3) |
Synonyms | hCG_37844 OK/SW-cl.8 NACB |
Description | FUNCTION: When associated with NACA, prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (ER). Binds to nascent polypeptide chains as they emerge from the ribosome and blocks their interaction with the signal recognition particle (SRP), which normally targets nascent secretory peptides to the ER. BTF3 is also a general transcription factor that can form a stable complex with RNA polymerase II. Required for the initiation of transcription. . |
Accessions | ENST00000678135.1 H0Y9Y1 ENST00000677654.1 ENST00000335895.12 [P20290-2] A0A7I2YQL2 P20290 A0A7I2V5Y3 ENST00000507081.6 ENST00000509708.2 A0A7I2V3T6 ENST00000676862.1 ENST00000380591.8 [P20290-1] D6RDG3 |